Amphastar Pharmaceuticals
Presencia
Amphastar Pharmaceuticals es una de las ...
Amphastar Pharmaceuticals es una empresa que cotiza bajo el símbolo de cotización AMPH (US).
Ejecutivos
Ver el organigrama con sus 9 ejecutivos principales
Biografías más buscadas en Amphastar Pharmaceuticals
- Jack Zhang, Chief Executive Officer, President, Chief Scientific O...
- Richard Prins, Lead Independent Director
- Gayle Deflin, Director
Crear su alerta
para seguir los movimientos de los ejecutivos en Amphastar Pharmaceuticals.
Farmacia
Amphastar Pharmaceuticals tiene 1.865 competidores entre los que se incluyen Pfizer (Estados Unidos), Sanofi (Francia) y Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacia
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado el 23 de marzo de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado el 19 de marzo de 2024).
- Frontier Medicines acaba de anunciar una recaudación de fondos de 80 millones de dólares. (publicado el 27 de febrero de 2024).
Otros contactos sugeridos en el sector Farmacia
Noticias
Últimos comunicados de prensa de Amphastar Pharmaceuticals
- Media/News | AMPHASTAR
- RSS News Feeds | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals Receives FDA Approval for Atropine Sulfate Injection | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals to Present at the Wells Fargo 2020 Virtual Healthcare Conference | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2020 | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6th, 2020 | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals to Present at the BMO Prescriptions for Success Healthcare Conference | Amphastar Pharmaceuticals, Inc.
- Press Releases | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals to Present at the Raymond James Virtual 2020 Human Healthcare Innovation Conference | Amphastar Pharmaceuticals, Inc.
- Amphastar Pharmaceuticals, Inc. Receives FDA Approval for Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) Multiple-Dose Vial | Amphastar Pharmaceuticals, Inc.
- View more press releases Close
Redes sociales sobre Amphastar Pharmaceuticals
- Amphastar Pharmaceuticals en Wikipedia, Google News y Yahoo Finance
- Amphastar Pharmaceuticals en LinkedIn, Twitter y YouTube
Ponerse en contacto
Contactar a través de e-mail con sus ejecutivos Jack Zhang 
Llame a Amphastar Pharmaceuticals al +1 909...
